CAAS Capital Management’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

CAAS Capital Management’s Portfolio ISLEW Stock Details ISLEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$2K	–	1067
2022 Q2	$2K	Hold	50,000	–	–	﹤0.01%	869
2022 Q1	$8K	Hold	50,000	–	–	﹤0.01%	604
2021 Q4	$25K	Hold	50,000	–	–	﹤0.01%	782
2021 Q3	$28K	Hold	50,000	–	–	﹤0.01%	849
2021 Q2	$35K	Hold	50,000	–	–	﹤0.01%	991
2021 Q1	$23K	Buy	+50,000	New	+$23.9K	﹤0.01%	1121

CAAS Capital Management's ISLEW Position: Q3 2022 in Review

CAAS Capital Management sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 50,000 shares — an estimated $2K sold.

CAAS Capital Management first reported a position in ISLEW in Q1 2021 and held it in 6 quarters. The position peaked at $35K in Q2 2021. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

CAAS Capital Management reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
CAAS Capital Management sold 50,000 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $2K.
CAAS Capital Management first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
CAAS Capital Management's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $35K in Q2 2021.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on CAAS Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.